Navigation Links
Leading cause of death in 'preemies' might be controlled by resetting a molecular switch
Date:12/2/2007

Washington, D.C. -- Blocking signals from a key molecular receptor that normally switches on the intestines immune response but instead becomes too intense in the presence of stress and toxins may help reverse necrotizing enterocolitis (NEC), a leading cause of death in premature newborns, according to scientists at the American Society for Cell Biology 47th annual meeting.

David J. Hackam and his laboratory team at the Childrens Hospital of Pittsburgh report that neonatal mice with inactivating mutations in the Toll-like receptor 4 (TLR4) are protected from NEC. Its a case of defenders becoming unwitting attackers, says Hackam.

Toll-like receptors are key players in the innate immune system. Protruding from enterocytes that form the innermost barrier-like layer of the small and large intestines, TLR4 receptors are primed to recognize pathogenic bacteria and sound the alarm.

But Hackams group found that the stresses of oxygen deprivation and bombardment by bacterial toxins, conditions that can occur in premature infants with underdeveloped lungs, stimulate too much production of TLR4. Like an unstoppable alarm, the increased numbers of TLR4 blare out signals that eventually tip the cells into cellular suicide. They also stop enterocytes from migrating to close wounds in the intestines.

These events, which do not occur in the TLR4-deficient mice, allow NEC to spread as the fragile lining of the gut gives way, releasing a flood of pathogens into the bloodstream. Even with modern advances in neonatal care, NEC affects 20 percent of premature babies and is fatal in nearly half of all cases, according to Hackam.

Hackams group discovered another way to switch off the molecular alarm in mice with NEC by interfering with production of a focal adhesion kinase (FAK) that the researchers found associated with TLR4. By shutting down FAK with small interfering RNA, the TLR4 siren was silenced. Under these conditions, the res
'/>"/>

Contact: John Fleischman
jfleischman@ascb.org
513-929-4635
American Society for Cell Biology
Source:Eurekalert

Page: 1 2

Related biology news :

1. M2SYS Partners with SecuGen Corporation to Support Market Leading Hamster Plus Fingerprint Reader with Auto-On Technology
2. Leading experts cite poor health and nutrition as major barrier to education in developing world
3. Ossur -- leading orthopedic pioneer - expands network to Asia
4. Leading researchers to reveal comprehensive dos and donts for prostate cancer
5. BIO-key(R) PocketCop(R) Project Leading the Nation According to Televised Report
6. Are current projections of climate change-impacts on biodiversity misleading?
7. Cleveland Clinic leading clinical program to improve early-stage lung cancer detection
8. deCODE discovers cause of major subtype of glaucoma
9. Study begins to reveal clues to the cause and progression of sepsis
10. Bleeding, not inflammation, is major cause of early lung infection death
11. Gamma globulin effective in treating eye infections caused by adenoviruses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...y of West African chimpanzees living in Cte d,Ivoi...pecies has dropped in numbers by a whopping 90 per...ago. The few remaining chimpanzees are now highly ... in Ta National Park, according to a report in the...ress publication. , This alarming decline in a c...
(Date:10/13/2008)... reveal why different parts of the brain can come ...MS). According to a new study in mice with an MS-l...duced by invading T cells dictates whether it,s th... The studyfrom researchers at the University of Ma...ton University in St. Louiswill be published onlin...
(Date:10/12/2008)...o available in French . , Researchers at McGi...hKline Inc. have identified two genetic variants i...evenfold increase the risk of male pattern baldnes...journal Nature Genetics. , About a third of al... 45. The condition,s social and economic impact is...
(Date:10/10/2008)... -- In a groundbreaking study led by an eminent mo...earchers have discovered that as embryonic stem ce...atic corresponding changes to the order in which D... bridge a critical knowledge gap for stem cell bio...ormously complex process by which DNA is repackage...
Breaking Biology News(10 mins):In a last 'stronghold' for endangered chimpanzees, survey finds drastic decline 2Researchers discover baldness gene: 1 in 7 men at risk 2Landmark study unlocks stem cell, DNA secrets to speed therapies 2Landmark study unlocks stem cell, DNA secrets to speed therapies 3Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2008 Results 15714 1Running Pioneer Kathrine Switzer Will Headline Women on the Move Conference August 13 15 2008 in Spearfish SD 15711 1Running Pioneer Kathrine Switzer Will Headline Women on the Move Conference August 13 15 2008 in Spearfish SD 15711 2Running Pioneer Kathrine Switzer Will Headline Women on the Move Conference August 13 15 2008 in Spearfish SD 15711 3MiMedx Group Announces Post split Name Change 4339 1MiMedx Group Announces Post split Name Change 4339 2MiMedx Group Announces Post split Name Change 4339 3Restrictive Prescription Drug Policies Hurt Schizophrenics 15708 1Restrictive Prescription Drug Policies Hurt Schizophrenics 15708 2
...minated this week by the continuing debate over HI...mang repeated yet again that drugs were not the on...ere also important. , After previously denying li...ment began providing AIDS drugs in clinics last ye... positive, which is more than any other nationalit...
...noma, studying functional tissue rather than cell ...s development, according to new research from a Ho...t Stanford University School of Medicine. , Though...melanoma development, scientists have not been abl...alterations and human cancer growth. Determining w...
...noma, studying functional tissue rather than cell ...s development, according to new research from a Ho...t Stanford University School of Medicine. , Though...melanoma development, scientists have not been abl...alterations and human cancer growth. Determining w...
...tistically significant improvements in clinical me...sia on the Etiology, Pathogenesis and Treatment of...eurologix,s Phase I trial showed positive interim ... year following treatment, patients exhibited a st...ion on the side of their body correlating to the t...
Other Biology News:Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance 2Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance 3Ibruprofen and other commonly used painkillers for treating inflammation may increase the risk of heart attack 2Ibruprofen and other commonly used painkillers for treating inflammation may increase the risk of heart attack 3Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 2Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 3Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 4Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 5Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 6
(Date:10/14/2008)... China, Oct. 14 /Xinhua--,C...ina-Biotics", "the,Company"), a leading Chinese fi...lopment, marketing and distribution of probiotics ... to list its common stock on the,Nasdaq Global Mar...he Nasdaq on October 23,2008, until which time it...
(Date:10/14/2008)... Va., Oct. 14 /- Insmed Inc...ogics and biopharmaceuticals, today,announced that...reverse,stock split, if necessary, at a Special Me...effort to meet the minimum bid price rule for cont...tember 3, 2008, the Company announced that the NAS...
(Date:10/14/2008)... China, Oct. 14 /Xinhua-- WuXi Pharma...eutical, biotechnology and,medical device research...ns,in China and the United States, today announced...for the third quarter ended September 30, 2008,an...Logo: http://www.newscom.com/cgi-bin/prnh/2004070...
(Date:10/13/2008)...ES, Oct. 13 /- Vista Partners announc...can Bio Medica Corporation,(Nasdaq: ABMC ) and ma...ss,Silver, Director of Research at Vista Partners ...e and sales from the Company,s lab,alliance, which... centers,continue to increase as well. The Compan...
Breaking Biology Technology:China-Biotics, Inc. Approved to List on the Nasdaq Global Market 2Insmed to Seek Shareholder Approval for Reverse Split 2Insmed to Seek Shareholder Approval for Reverse Split 3WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 2WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 3WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 4WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 5WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 6WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 7WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 8Vista Partners Updates Coverage; Maintains $3.20 Target Price 2
...ulk and custom kits made-to-order , Cust... Stringent quality control guaranteed , ... , Ambion Custom has a staff of R&D and ... plan your research and design products specifical...oduct can be customized. You specify the volumes a...
...lencer Validated siRNAs are single siRNA duplexes ...-PCR to reduce the expression of a number of impor... validation is a >70% reduction in , targ...ugh the average , reduction in target gen... , is greater than 90%. Every Silencer Va...
... , , , Application Gu........................................................on .................................................................................2 , II. P........................................................
...lication Guide, ,I. Description ,II. Prod...by the User ,IV. Protocol for Extraction of DN...Genome Amplification from Soil ,VI. Quantifica...of Amplified Products , ,Appendix, , R...,Application Guide, , I. Description ,T...
Other Biology Technology:Ambion Custom: Made-to-Order 2Ambion Custom: Made-to-Order 3Silencer Validated siRNAs 2Silencer Validated siRNAs 3Silencer Validated siRNAs 4Silencer Validated siRNAs 5Silencer Validated siRNAs 6Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 2Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 3Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 4Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 5Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 6Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 7Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 8Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 9Protocol for GenomePlex Whole Genome Amplification from Soil 2Protocol for GenomePlex Whole Genome Amplification from Soil 3Protocol for GenomePlex Whole Genome Amplification from Soil 4Protocol for GenomePlex Whole Genome Amplification from Soil 5
JAB1 Immunogen: Synthetic peptide, conjugated to KLH, corresponding to residues S(201) E Y Q T I P L N K I E D F G V(216) of human JAB1. The sequence is identical in mouse and rat. Storage: -
Hamartin/TSC1 (1B2) Mouse mAb Ship: Hot Store: -20 C
Blank Calibration Particles, 3.0-3.4 mu m 5 ml
synaptotagmin XIV-like [Source:RefSeq_peptide;Acc:NP_114120] Antigen: Recombinant Protein Epitope Signature Tag (PrEST).
Biology Products: